163 related articles for article (PubMed ID: 1606346)
1. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media.
Spinler SA; Goldfarb S
Ann Pharmacother; 1992 Jan; 26(1):56-64. PubMed ID: 1606346
[TBL] [Abstract][Full Text] [Related]
2. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
Duan SB; Wang YH; Liu FY; Xu XQ; Wang P; Zou Q; Peng YM
Acta Radiol; 2009 Sep; 50(7):754-9. PubMed ID: 19452295
[TBL] [Abstract][Full Text] [Related]
3. [Influence of high- and low-osmolality contrast media on renal function in children].
Chen CY; Cao L; Chen DK; Chu M; Tu J
Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):280-4. PubMed ID: 16780650
[TBL] [Abstract][Full Text] [Related]
4. Comparative cytotoxicity of high-osmolar and low-osmolar contrast media on HKCs in vitro.
Duan S; Zhou X; Liu F; Peng Y; Chen Y; Pei Y; Ling G; Zhou L; Li Y; Pi Y; Tang K; Liu R; Li G
J Nephrol; 2006; 19(6):717-24. PubMed ID: 17173243
[TBL] [Abstract][Full Text] [Related]
5. Comparative tolerability of contrast media used for coronary interventions.
Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
[TBL] [Abstract][Full Text] [Related]
6. [The effects of contrast media on the cardiac conducting system in coronary angiography].
Kawamori J
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Nov; 49(11):1372-81. PubMed ID: 2602100
[TBL] [Abstract][Full Text] [Related]
7. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials.
Pandya B; Chalhoub JM; Parikh V; Gaddam S; Spagnola J; El-Sayegh S; Bogin M; Kandov R; Lafferty J; Bangalore S
Int J Cardiol; 2017 Feb; 228():137-144. PubMed ID: 27863354
[TBL] [Abstract][Full Text] [Related]
8. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
9. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
Solomon R; Dumouchel W
Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
[TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity related to contrast media.
Berg KJ
Scand J Urol Nephrol; 2000 Oct; 34(5):317-22. PubMed ID: 11186471
[TBL] [Abstract][Full Text] [Related]
11. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
Barrett BJ; Carlisle EJ
Radiology; 1993 Jul; 188(1):171-8. PubMed ID: 8511292
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
13. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology?
Henry DA; Evans DB; Robertson J
Med J Aust; 1991 Jun; 154(11):766-72. PubMed ID: 1828529
[TBL] [Abstract][Full Text] [Related]
14. [Nephrotoxicity of high- and low-osmolar contrast media: Protective role of fosinopril or telmisartan in a rat model].
Duan SB; Zou Q; Li YJ; Peng YM; Liu FY; Wang YH; Xu XQ; Jiang WL; Liu YH; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):812-8. PubMed ID: 18007076
[TBL] [Abstract][Full Text] [Related]
15. Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model.
Duan SB; Liu FY; Luo JA; Wu HW; Liu RH; Peng YM; Yang XL
Acta Radiol; 2000 Sep; 41(5):503-7. PubMed ID: 11016776
[TBL] [Abstract][Full Text] [Related]
16. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
17. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
18. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Schönefeld E; Höwler S; Osada N; Torsello G
Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
Wang YC; Tang A; Chang D; Lu CQ; Zhang SJ; Ju S
Am J Cardiol; 2016 Oct; 118(7):985-90. PubMed ID: 27521223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
